Basic strategy for avoiding drug interaction during stage of drug development; proposals relative to planning of non-clinical and clinical studies and how clinical trials should be planned.
Horie
T
T
Tsukuba Research Loboratories, Eisai Co., Ltd., Ibaraki, Japan.
Nakata
H
H
Kusube
K
K
D000595:Amino Acid Sequence; D000818:Animals; D002986:Clinical Trials as Topic / Q000379:methods*; D015195:Drug Design; D004341:Drug Evaluation / Q000379:methods*; D004353:Drug Evaluation, Preclinical / Q000379:methods; D004347:Drug Interactions; D064420:Drug-Related Side Effects and Adverse Reactions; D006801:Humans; D008969:Molecular Sequence Data